3-aryl-6-aralkyl-1, 4, 5, 6-tetrahydropyridazine compound and preparation method and application thereof
A tetrahydropyridazine and compound technology, which is applied in the field of nitrogen-containing heterocyclic compounds, can solve the problems of large limitation of substrates and troublesome post-processing, and achieves the effects of short synthesis route, simple post-processing and good application value.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0076] The present invention also provides a preparation method of 3-aryl-6-aralkyl-1,4,5,6-tetrahydropyridazine compounds, comprising the following steps:
[0077] 1) After mixing and reacting the compound having the structure of formula II, arylsulfonyl hydrazide and the first solvent, the compound having the structure of formula III is obtained;
[0078] 2) Under the conditions of an airtight and protective atmosphere, after the compound with the structure of formula III obtained in the above steps, the base, the catalyst and the second solvent are subjected to a photocatalytic reaction, the 3-aryl- 6-aralkyl-1,4,5,6-tetrahydropyridazines;
[0079]
[0080] Among them, R 1 , R 2 each selected from H, CH 3 ;
[0081] R 3 selected from CH 3 ; 4 selected from CH 3 or H;
[0082] The R 3 and R 4 It is also possible to cyclosynthesize cyclopentyl, cyclohexyl, 4-tetrahydropyranyl or cycloheptyl;
[0083] Ar 1 selected from phenyl, 4-chlorophenyl, 4-bromophenyl, 4-...
Embodiment 1
[0127] Dissolve 1-phenyl-5-methyl-4-hexen-1-one (1.0 equiv) in methanol, add p-toluenesulfonyl hydrazide (1.1 equiv) at room temperature, and react for 24 hours to obtain N-4-methyl phenylsulfonyl-1-phenyl-5-methyl-4-hexene-1-hydrazone. Add the obtained unsaturated hydrazone (1.0 equiv), potassium pivalate (1.0 equiv), tris(2,2'-bipyridyl) ruthenium bis(hexafluorophosphate) salt (0.03 equiv) into a sealed tube, and argon After three replacements, dichloroethane was added and reacted for 12 hours under 22W blue light to obtain 3-phenyl-6-[1,1-dimethyl-1-(4-methylphenyl)]methylene- 1,4,5,6-tetrahydropyridazine (I-1), yield 85%.
[0128] 1 H NMR (400MHz, CDCl 3 )δ7.64(d, J=7.3Hz, 2H), 7.35(dd, J=4.9, 2.9Hz, 3H), 7.32–7.26(m, 2H), 7.21(d, J=7.9Hz, 2H), 5.39(s,1H),3.20(d,J=11.0Hz,1H),2.71(dd,J=8.6,4.3Hz,2H),2.39(s,3H),2.18–2.05(m,1H),1.96 –1.79(m,1H),1.44(d,J=12.6Hz,6H); 13 C NMR (150MHz, CDCl 3 )δ143.9, 143.0, 138.5, 135.9, 129.2, 128.2, 128.1, 127.6, 126.1, 124.2, 60.5, 39...
Embodiment 2
[0130]Dissolve 1-(4-chlorophenyl)-5-methyl-4-hexen-1-one (1.0 equiv) in methanol, add p-toluenesulfonyl hydrazide (1.1 equiv) at room temperature, and react for 24 hours to obtain N-4-Methylbenzenesulfonyl-1-(4-chlorophenyl)-5-methyl-4-hexene-1-hydrazone. Add the obtained unsaturated hydrazone (1.0 equiv), potassium pivalate (1.0 equiv), tris(2,2'-bipyridine) ruthenium bis(hexafluorophosphate) salt (0.03 equiv) into a sealed tube, and argon After three replacements, dichloroethane was added and reacted under 22W blue light for 12 hours to obtain 3-(4-chlorophenyl)-6-[1,1-dimethyl-1-(4-methylphenyl) ] Methylene-1,4,5,6-tetrahydropyridazine (I-2), yield 71%.
[0131] 1H NMR (400MHz, CDCl 3 )δ7.57–7.44(m,2H),7.26(ddd,J=9.2,6.6,5.0Hz,4H),7.15(d,J=8.0Hz,2H),3.14(dd,J=11.2,2.1Hz ,1H),2.66–2.56(m,2H),2.33(s,3H),2.11–2.00(m,1H),1.88–1.72(m,1H),1.38(s,3H),1.36(s,3H ); 13 C NMR (100MHz, CDCl 3 )δ143.8,141.5,137.0,136.0,133.3,129.3,128.3,126.1,125.4,60.4,39.2,26.0,24.0,21.7,20.8,20...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


